| Primary |
| Epilepsy |
30.1% |
| Convulsion |
15.1% |
| Lennox-gastaut Syndrome |
8.6% |
| Myoclonic Epilepsy |
8.6% |
| Grand Mal Convulsion |
6.5% |
| Status Epilepticus |
5.4% |
| Pain |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Supplementation Therapy |
3.2% |
| Carbon Monoxide Poisoning |
2.2% |
| Complex Partial Seizures |
2.2% |
| Depression |
2.2% |
| Petit Mal Epilepsy |
2.2% |
| Asthma |
1.1% |
| Autism |
1.1% |
| Facial Pain |
1.1% |
| Hypothyroidism |
1.1% |
| Ill-defined Disorder |
1.1% |
| Infantile Spasms |
1.1% |
| Infected Insect Bite |
1.1% |
|
| Vomiting |
13.6% |
| Weight Decreased |
11.4% |
| Convulsion |
9.1% |
| Drug Withdrawal Convulsions |
9.1% |
| Grand Mal Convulsion |
6.8% |
| Gastrooesophageal Reflux Disease |
4.5% |
| Injury |
4.5% |
| Neutropenia |
4.5% |
| Tremor |
4.5% |
| Urinary Tract Infection |
4.5% |
| White Blood Cell Count Decreased |
4.5% |
| Wrist Fracture |
4.5% |
| Abdominal Pain |
2.3% |
| Bacteraemia |
2.3% |
| Blindness |
2.3% |
| Condition Aggravated |
2.3% |
| Dermatitis Allergic |
2.3% |
| Drug Administration Error |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
| Drug Ineffective |
2.3% |
|
| Secondary |
| Convulsion |
25.3% |
| Product Used For Unknown Indication |
24.1% |
| Myoclonic Epilepsy |
22.8% |
| Epilepsy |
10.1% |
| Grand Mal Convulsion |
5.1% |
| Infantile Spasms |
3.8% |
| Complex Partial Seizures |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Ill-defined Disorder |
1.3% |
| Rosacea |
1.3% |
| Supplementation Therapy |
1.3% |
|
| Weight Decreased |
15.2% |
| Abdominal Pain |
13.0% |
| Staring |
13.0% |
| Vomiting |
13.0% |
| Condition Aggravated |
4.3% |
| Drug Withdrawal Convulsions |
4.3% |
| Grand Mal Convulsion |
4.3% |
| Incorrect Dose Administered |
4.3% |
| Injury |
4.3% |
| Convulsion |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Drug Ineffective |
2.2% |
| Drug Level Decreased |
2.2% |
| Hemiparesis |
2.2% |
| Intentional Drug Misuse |
2.2% |
| Red Blood Cell Sedimentation Rate Increased |
2.2% |
| Road Traffic Accident |
2.2% |
| Sleep Disorder |
2.2% |
| Somnolence |
2.2% |
| Splenomegaly |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.3% |
| Epilepsy |
15.3% |
| Convulsion |
14.1% |
| Complex Partial Seizures |
6.6% |
| Asthma |
5.0% |
| Convulsion Prophylaxis |
3.0% |
| Infantile Spasms |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Lennox-gastaut Syndrome |
1.5% |
| Multiple Sclerosis |
1.3% |
| Psoriasis |
1.3% |
| Drug Use For Unknown Indication |
1.2% |
| Insomnia |
1.2% |
| Restless Legs Syndrome |
1.2% |
| Cerebrovascular Accident Prophylaxis |
1.0% |
| Cough |
1.0% |
| Grand Mal Convulsion |
1.0% |
| Hypertension |
1.0% |
| Oedema Peripheral |
1.0% |
| Prophylaxis |
1.0% |
|
| Convulsion |
21.1% |
| Drug Ineffective |
13.7% |
| Vomiting |
7.4% |
| Weight Increased |
6.3% |
| Sepsis |
5.3% |
| Urinary Tract Infection |
5.3% |
| Visual Field Defect |
5.3% |
| Somnolence |
4.2% |
| Congestive Cardiomyopathy |
3.2% |
| Drug Dose Omission |
3.2% |
| Hallucination, Auditory |
3.2% |
| Pneumonia |
3.2% |
| Rash Pruritic |
3.2% |
| Withdrawal Syndrome |
3.2% |
| Condition Aggravated |
2.1% |
| Diarrhoea |
2.1% |
| Hypersensitivity |
2.1% |
| Hypotension |
2.1% |
| Insomnia |
2.1% |
| No Therapeutic Response |
2.1% |
|
